A generics specialist facing a localisation imperative
Our client is a mid-sized European pharmaceutical group manufacturing generic and branded-generic medicines for hospital and retail channels. The group had supplied the Saudi market through a local distributor for over a decade, with the Kingdom representing its largest single export market in the region.
Saudi Arabia's procurement landscape changed the calculus: government purchasing through NUPCO increasingly favours locally manufactured products, and the national localisation programme offers pricing preferences, faster registration pathways and volume commitments to manufacturers producing inside the Kingdom. Remaining an importer meant progressively losing tenders to localised competitors.
Pharma localisation under Vision 2030
Healthcare is one of Vision 2030's priority localisation sectors. The combination of NUPCO's centralised procurement, SFDA's support for local manufacturing registration, and industrial incentives through MODON and the Saudi Industrial Development Fund has triggered a wave of pharmaceutical plant announcements. For established exporters, the window to localise ahead of tender-cycle lock-in is finite.
The group's board approved a phased localisation: an initial secondary-packaging and quality-control facility in Riyadh, expanding to full formulation within three years. Incorporated was engaged to deliver the corporate, industrial and regulatory foundation — everything short of the plant engineering itself.
"Pharmaceutical setups fail on sequencing — if the SFDA, MODON and MISA steps are not aligned, you burn months. Incorporated ran the three tracks in parallel and our facility was licence-complete before our equipment cleared customs."
Group Chief Operating Officer — European Pharmaceutical ManufacturerThree regulatory tracks, one programme
Incorporated structured the engagement as three parallel tracks — corporate, industrial and pharmaceutical — with dependencies mapped so no track waited unnecessarily on another.
Incorporated secured a MISA industrial licence for the 100% foreign-owned subsidiary, with activity codes spanning pharmaceutical manufacturing, packaging and wholesale distribution. CR issuance, Chamber registration, ZATCA, GOSI and HRSD activation followed the standard incorporation sequence, with the general manager's visa and Iqama processed so a resident authorised signatory was in place for the industrial applications.
In parallel, Incorporated obtained the industrial licence from the Ministry of Industry and Mineral Resources and coordinated the allocation of a pre-built pharmaceutical-grade facility in Riyadh's Second Industrial City through MODON. Environmental permitting through the National Center for Environmental Compliance, Civil Defense fire-safety certification and utility connections were sequenced against the client's fit-out programme.
Incorporated coordinated the SFDA establishment licensing pathway: facility registration, appointment of the qualified pharmacist-in-charge, and preparation for the GMP inspection covering the packaging and QC laboratory scope. Product registration dossiers for the first tranche of transferred products were sequenced so marketing authorisation variations landed as the facility came online.
Incorporated built the entity's Saudization plan around SFDA's pharmacist localisation requirements, processed visas for the technical transfer team, and prepared the group's applications for localisation incentives and NUPCO local-content classification. The phase-two formulation expansion is now in planning under the same structure.
Authorities engaged on this mandate
Pharmaceutical manufacturing is among the most approval-intensive setups in the Kingdom. Incorporated managed each track end to end:
MISA & Ministry of Commerce
Industrial investment licence with manufacturing and distribution activities; CR issuance and corporate registrations.
SFDA — Saudi Food & Drug Authority
Establishment licence, pharmacist-in-charge appointment, GMP inspection readiness and product registration transfer for locally packaged lines.
Ministry of Industry & MODON
Industrial licence, industrial-city facility allocation, and eligibility groundwork for industrial incentives and SIDF financing.
NCEC & Civil Defense
Environmental compliance permitting for the facility and fire-safety certification ahead of equipment installation.
ZATCA & Saudi Customs
VAT registration, customs importer code and duty treatment for production equipment and pharmaceutical inputs.
HRSD, GOSI & Employment Portals
Labour file, Saudization planning around SFDA pharmacist requirements, and Qiwa/Muqeem/Mudad activation for the technical workforce.
Why the engagement succeeded
- 01
Parallel-track sequencing. Corporate, industrial and SFDA workstreams ran simultaneously with mapped dependencies — the facility was licence-complete before production equipment arrived, avoiding an idle-asset period the client had budgeted at six months.
- 02
Regulator-specific expertise. SFDA establishment licensing and GMP readiness demand different documentation cultures than MISA or MODON. Incorporated's team prepared each authority's file in its own format, eliminating rework cycles.
- 03
Localisation economics captured. The entity was structured from day one to qualify for local-content classification in NUPCO tenders and industrial incentive programmes — the commercial rationale for the entire project.
- 04
Workforce compliance built around the science. Saudization planning was designed around SFDA's pharmacist localisation rules, so regulatory staffing and Nitaqat compliance reinforced rather than conflicted with each other.